Enveric Biosciences Inc. (ENVB): Price and Financial Metrics
ENVB Price/Volume Stats
| Current price | $1.72 | 52-week high | $28.05 |
| Prev. close | $1.82 | 52-week low | $1.13 |
| Day low | $1.67 | Volume | 136,300 |
| Day high | $1.82 | Avg. volume | 3,828,328 |
| 50-day MA | $3.46 | Dividend yield | N/A |
| 200-day MA | $6.61 | Market Cap | 1.17M |
ENVB Stock Price Chart Interactive Chart >
Enveric Biosciences Inc. (ENVB) Company Bio
Enveric Biosciences Inc., formerly AMERI Holdings, Inc., is a patient-central biotechnology company. The Company is focused on enhancing lives of people affected by the side effects of cancer treatments, such as radiodermatitis and chemotherapy-induced peripheral neuropathy. The Company is engaged in leveraging its clinical developments derived from ... More
ENVB Price Returns
| 1-mo | 3.61% |
| 3-mo | -67.97% |
| 6-mo | -77.07% |
| 1-year | -91.31% |
| 3-year | -99.18% |
| 5-year | -99.94% |
| YTD | -68.01% |
| 2024 | -72.43% |
| 2023 | -37.50% |
| 2022 | -95.53% |
| 2021 | -78.17% |
| 2020 | N/A |
Loading social stream, please wait...